AVITA Medical (RCEL, Financial) continues to draw confidence from analysts as highlighted by the recent report from D. Boral Capital. Analyst Jason Kolbert has maintained his 'Buy' rating on the stock.
The price target for AVITA Medical (RCEL, Financial) stands firm at $19.00 USD, unchanged from previous assessments. This reflects a steady outlook on the company's potential in the market.
Dated June 6, 2025, the report underscores consistent expectations for AVITA Medical (RCEL, Financial), as the maintained price target and rating have not deviated from prior evaluations.
Investors keeping an eye on AVITA Medical (RCEL, Financial) will note the consistency of analyst sentiment, which underscores trust in the company's prospects. The insights from Jason Kolbert at D. Boral Capital could provide a benchmark for those considering adjustments to their portfolios.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 4 analysts, the average target price for AVITA Medical Inc (RCEL, Financial) is $16.88 with a high estimate of $22.00 and a low estimate of $12.50. The average target implies an upside of 193.48% from the current price of $5.75. More detailed estimate data can be found on the AVITA Medical Inc (RCEL) Forecast page.
Based on the consensus recommendation from 7 brokerage firms, AVITA Medical Inc's (RCEL, Financial) average brokerage recommendation is currently 2.4, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for AVITA Medical Inc (RCEL, Financial) in one year is $23.33, suggesting a upside of 305.74% from the current price of $5.75. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the AVITA Medical Inc (RCEL) Summary page.